Titre : | Efficacy of the customized employment supports (CES) model of vocational rehabilitation for unemployed methadone patients : preliminary results |
Titre traduit : | (Efficacité d'un modèle de soutien pour retrouver un emploi rémunéré dans le cadre de la réinsertion professionnelle de patients sous méthadone sans emploi : premiers résultats) |
Auteurs : | G. L. STAINES ; L. BLANKERTZ ; S. MAGURA ; P. BALI ; MADISON E. M. ; SPINELLI M. ; HOROWITZ E. ; H. GUARINO ; GRANDY A. ; C. FONG ; A. GOMEZ ; DIMUN A. ; E. FRIEDMAN |
Type de document : | Périodique |
Année de publication : | 2004 |
Format : | 2261-2285 / tabl. |
Note générale : |
Substance Use and Misuse, 2004, 39, (13-14), 2261-2285 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés REINSERTION PROFESSIONNELLE ; PROGRAMME ; METHADONE ; EFFICACITE |
Résumé : |
ENGLISH : This article presents initial efficacy data for an innovative vocational rehabilitation model designed for methadone-maintained patientsthe Customized Employment Supports (CES) model. In this model, a CES counselor works intensively with a small caseload of patients in order to overcome the vocational as well as nonvocational barriers that hinder their employment, with the goal of attaining rapid placement in competitive employment. The CES model was implemented at two Manhattan methadone treatment programs as part of a randomized clinical trial comparing the model's employment outcomes with those of standard vocational counseling. The study tested the hypothesis that patients in the experimental group will have better employment outcomes than those in the comparison group. The data were collected from May 2001 through September 2003. The sample consisted of the first 121 patients who had completed their 6-month follow-up interviews. The preliminary results supported the hypothesis for two indices of paid employment, i.e., the CES group was more likely to obtain both competitive employment and informal paid employment. The clinical trial is continuing. (Review' s abstract) |
Note de contenu : | tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 9 |
Affiliation : |
National Development and Research Institutes, 71 W. 23rd St., 8th floor, New York, 10010. E-mail : magura@ndri.org Etats-Unis. United States. |
Numéro Toxibase : | 404707 |
Centre Emetteur : | 04 CIRDD-51 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil